Screening of patients with rheumatism improves insight into cardiovascular disease

March 21, 2014

Since the fifties, researchers have observed that patients with rheumatoid arthritis have an increased mortality from cardiovascular disease. Patients with this form of rheumatism were approximately 50% more likely to suffer from cardiovascular disease (relatively often fatal) compared with healthy peers of the same gender. PhD candidate Inger Meek of the University of Twente has performed research on multiple forms of rheumatic disease and the risk of cardiovascular disease. Patients with gout have a particularly high risk of cardiovascular disease.

In comparison with the rest of the population, there is a higher risk of in with a , not only in patients with , as historical research indicates. Rheumatoid arthritis is an autoimmune disease: the immune system turns against its own body and inflammations in the joints develop. The research by Meek in a group of patients with various rheumatic diseases shows that gout patients have the most unfavourable risk profile of all the risk factors examined. Gout is a rheumatic disease in which uric acid crystals are deposited in the joints. This is because of poor metabolism in the body, with the result that uric acid accumulates.

Careful with painkillers

It has also been shown that a continuous use of ibuprofen as a painkiller doesn't seem to do much for the risk of cardiovascular disease. On the other hand, the risk for patients with rheumatoid arthritis is actually lower when they are treated with the drug methotrexate. And, in contrast to the current guidelines, the drug naproxen (ananti-inflammatory painkiller) should be avoided in patients at risk who are also taking aspirin to prevent a heart attack. "Our study shows that the combination of naproxen with aspirin inhibits the anti-clotting effect of aspirin."

Screening of patients

The data for Meek's study comes from the cohort Arthritis Center Twente Cardiovascular Disease (CVD ACT). Since 2009, the patients at the Arthritis Center Twente have been screened for risk factors for cardiovascular disease. The results of this screening are stored anonymously in a database, and patients are regularly monitored for the occurrence of new cardiovascular disease and death.

Fatality rate is decreasing

Three years after the screening, the risk of rheumatoid arthritis patients from the ACT-CVD cohort getting cardiovascular disease for the first time did not increase compared to osteoarthritis patients, whereas this was the case in historical cohorts. Osteoarthritis is a rheumatic condition in which the cartilage deteriorates in quality and becomes thinner and softer. The proportion of cardiovascular disease with a fatal outcome was 6.9% in the ACT CVD cohort, a marked decrease compared to the 52.9% fatality rate in a similar cohort from 1998 with higher disease activity.

Explore further: Rheumatoid arthritis and heart disease: Studies shed light on dangerous connection

Related Stories

Rheumatoid arthritis and heart disease: Studies shed light on dangerous connection

October 26, 2013
People with rheumatoid arthritis and other chronic inflammatory conditions are at higher risk of heart disease. Who is in the most danger, why and how best to prevent and detect cardiovascular complications are important ...

Hip, knee replacements may boost cardiovascular health in osteoarthritis patients

March 11, 2014
Hip and knee replacements have long been known to reduce pain and increase mobility in persons with moderate-to-severe arthritis. A study presented at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons ...

Big toe isn't biggest culprit in gout flare-ups; other joints tied to higher risk

June 11, 2013
The painful rheumatic condition gout is often associated with the big toe, but it turns out that patients at highest risk of further flare-ups are those whose gout first involved other joints, such as a knee or elbow, Mayo ...

Rheumatoid arthritis patients can get gout too, study finds

November 10, 2012
Refuting a belief long held by many physicians, a Mayo Clinic study found that rheumatoid arthritis patients also can get gout. The research is among several studies Mayo Clinic is presenting at the American College of Rheumatology ...

Standard heart disease risk tools underrate danger in rheumatoid arthritis

May 21, 2012
Heart disease risk assessment tools commonly used by physicians often underestimate the cardiovascular disease danger faced by rheumatoid arthritis patients, a Mayo Clinic study has found. Inflammation plays a key role in ...

Higher mortality in postmenopausal women with RA and anti-CCP antibodies

December 23, 2013
New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology ...

Recommended for you

Study shows prevalence of knee osteoarthritis has doubled since World War II

August 14, 2017
The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons most might think.

Researchers find arthritis drug could treat blood cancer patients

August 3, 2017
Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.